These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The use of adjunctive therapy to alter the pathophysiology of bacterial meningitis. Roos KL Clin Neuropharmacol; 1995 Apr; 18(2):138-47. PubMed ID: 8635173 [TBL] [Abstract][Full Text] [Related]
6. Bacterial meningitis: recent advances in pathophysiology and treatment. Tunkel AR; Wispelwey B; Scheld WM Ann Intern Med; 1990 Apr; 112(8):610-23. PubMed ID: 2183667 [TBL] [Abstract][Full Text] [Related]
7. Potential role of the Virchow Robin space in the pathogenesis of bacterial meningitis. Chan P; Meerdink DJ; Uchizono JA Med Hypotheses; 2017 Nov; 109():114-118. PubMed ID: 29150269 [TBL] [Abstract][Full Text] [Related]
8. Models of experimental bacterial meningitis. Role and limitations. Koedel U; Pfister HW Infect Dis Clin North Am; 1999 Sep; 13(3):549-77, vi. PubMed ID: 10470555 [TBL] [Abstract][Full Text] [Related]
9. Nasal lymphatics as a novel invasion and dissemination route of bacterial meningitis. Filippidis A; Fountas KN Med Hypotheses; 2009 Jun; 72(6):694-7. PubMed ID: 19243893 [TBL] [Abstract][Full Text] [Related]
11. Drug Insight: adjunctive therapies in adults with bacterial meningitis. van de Beek D; Weisfelt M; de Gans J; Tunkel AR; Wijdicks EF Nat Clin Pract Neurol; 2006 Sep; 2(9):504-16. PubMed ID: 16932615 [TBL] [Abstract][Full Text] [Related]
12. Adjunctive therapy for bacterial meningitis: rationale for use, current status, and prospects for the future. Townsend GC; Scheld WM Clin Infect Dis; 1993 Nov; 17 Suppl 2():S537-49. PubMed ID: 8274621 [TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of bacterial meningitis: contributions by experimental models in rabbits. Täuber MG; Sande MA Infection; 1984; 12 Suppl 1():S3-10. PubMed ID: 6397452 [TBL] [Abstract][Full Text] [Related]
15. Bacterial meningitis in the patient at risk: intrinsic risk factors and host defense mechanisms. Scheld WM Am J Med; 1984 May; 76(5A):193-207. PubMed ID: 6372470 [TBL] [Abstract][Full Text] [Related]
16. Reprogramming the host response in bacterial meningitis: how best to improve outcome? van der Flier M; Geelen SP; Kimpen JL; Hoepelman IM; Tuomanen EI Clin Microbiol Rev; 2003 Jul; 16(3):415-29. PubMed ID: 12857775 [TBL] [Abstract][Full Text] [Related]
17. Treatment strategies for central nervous system infections: an update. Tan YC; Gill AK; Kim KS Expert Opin Pharmacother; 2015 Feb; 16(2):187-203. PubMed ID: 25328149 [TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and pathophysiology of meningitis. Tunkel AR; Wispelwey B; Scheld WM Infect Dis Clin North Am; 1990 Dec; 4(4):555-81. PubMed ID: 2277188 [TBL] [Abstract][Full Text] [Related]
19. [Supportive (antiinflammatory) treatment of bacterial meningoencephalitis with dexamethasone]. Szychowska Z Pol Merkur Lekarski; 1997 Apr; 2(10):291-4. PubMed ID: 9377671 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in the pathogenesis and pathophysiology of bacterial meningitis. Quagliarello VJ; Scheld WM Am J Med Sci; 1986 Nov; 292(5):306-9. PubMed ID: 3535498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]